Replimune Group, Inc.·4

Apr 7, 9:08 PM ET

Peeples-Dyer Veleka 4

4 · Replimune Group, Inc. · Filed Apr 7, 2026

Research Summary

AI-generated summary of this filing

Updated

Replimune Group (REPL) Director Veleka Peeples-Dyer Receives Award

What Happened
Veleka Peeples-Dyer, a director of Replimune Group, was granted 44,500 derivative shares/options on April 1, 2026. The award was recorded at $0.00 per share (no cash paid), so the reported acquisition value is $0. The filing notes the underlying shares vest in full on April 1, 2027. The Form 4 was filed late due to an inadvertent administrative error.

Key Details

  • Transaction date: 2026-04-01. Transaction code: A (award/grant of a derivative security).
  • Amount: 44,500 shares; Price/Consideration: $0.00 per share; reported dollar value: $0.
  • Vesting: Footnote indicates all shares underlying this option vest on 2027-04-01.
  • Shares owned after transaction: Not disclosed in this Form 4.
  • Filing timeliness: Late filing noted in the remarks (inadvertent administrative error). This reduces short-term transparency until corrected.

Context
This was a grant/award of a derivative security (not a cash purchase or a sale). Because the award vests later, there is no immediate change in tradable shares unless/until vested and exercised. Grants to directors are typically compensation-related; they do not by themselves indicate a buy or sell decision by the insider. The late filing corrects the public record but does not, by itself, provide insight into the insider’s trading intent.

Insider Transaction Report

Form 4
Period: 2026-04-01
Transactions
  • Award

    Stock Option (right to buy)

    [F1]
    2026-04-01+44,50044,500 total
    Exercise: $7.61Exp: 2036-04-01Common Stock (44,500 underlying)
Footnotes (1)
  • [F1]The shares underlying this option vest entirely on April 1, 2027.
Signature
/s/ Shawn Glidden, attorney-in-fact|2026-04-07

Documents

1 file
  • 4
    tm2611350-9_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT